FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1983846798> ?p ?o ?g. }

• W1983846798 endingPage "1140" @default.
• W1983846798 startingPage "1129" @default.
• W1983846798 abstract "Growth arrest is one of the essential features of cellular senescence. At present, the precise mechanisms responsible for the establishment of the senescence-associated arrested phenotype are still incompletely understood. Given that ERK1/2 is one of the major kinases controlling cell growth and proliferation, we examined the possible implication of ERK1/2. Exposure of normal rat epithelial cells to etoposide caused cellular senescence, as manifested by enlarged cell size, a flattened cell body, reduced cell proliferation, enhanced β-galactosidase activity, and elevated p53 and p21. Senescent cells displayed a blunted response to growth factor-induced cell proliferation, which was preceded by impaired ERK1/2 activation. Further analysis revealed that senescent cells expressed a significantly higher level of mitogen-activated protein phosphatase 3 (MKP-3, a cytosolic ERK1/2-targeted phosphatase), which was suppressed by blocking the transcriptional activity of the tumor suppressor p53 with pifithrin-α. Inhibition of MKP-3 activity with a specific inhibitor or siRNA enhanced basal ERK1/2 phosphorylation and promoted cell proliferation. Apart from its role in growth arrest, impairment of ERK1/2 also contributed to the resistance of senescent cells to oxidant-elicited cell injury. These results therefore indicate that p53-mediated up-regulation of MKP-3 contributes to the establishment of the senescent cellular phenotype through dephosphorylating ERK1/2. Impairment of ERK1/2 activation could be an important mechanism by which p53 controls cellular senescence.Growth arrest is a hallmark of cellular senescence.ResultsLoss of cell proliferation in senescent cells was associated with impaired ERK1/2 activation, which was caused by p53-mediated elevation of MKP-3.ConclusionThe p53/MKP-3/ERK1/2 cascade contributed to the establishment of the senescent phenotype.SignificanceOur study provides novel insights into the actions and mechanisms of p53 on cellular senescence. Growth arrest is one of the essential features of cellular senescence. At present, the precise mechanisms responsible for the establishment of the senescence-associated arrested phenotype are still incompletely understood. Given that ERK1/2 is one of the major kinases controlling cell growth and proliferation, we examined the possible implication of ERK1/2. Exposure of normal rat epithelial cells to etoposide caused cellular senescence, as manifested by enlarged cell size, a flattened cell body, reduced cell proliferation, enhanced β-galactosidase activity, and elevated p53 and p21. Senescent cells displayed a blunted response to growth factor-induced cell proliferation, which was preceded by impaired ERK1/2 activation. Further analysis revealed that senescent cells expressed a significantly higher level of mitogen-activated protein phosphatase 3 (MKP-3, a cytosolic ERK1/2-targeted phosphatase), which was suppressed by blocking the transcriptional activity of the tumor suppressor p53 with pifithrin-α. Inhibition of MKP-3 activity with a specific inhibitor or siRNA enhanced basal ERK1/2 phosphorylation and promoted cell proliferation. Apart from its role in growth arrest, impairment of ERK1/2 also contributed to the resistance of senescent cells to oxidant-elicited cell injury. These results therefore indicate that p53-mediated up-regulation of MKP-3 contributes to the establishment of the senescent cellular phenotype through dephosphorylating ERK1/2. Impairment of ERK1/2 activation could be an important mechanism by which p53 controls cellular senescence.Growth arrest is a hallmark of cellular senescence. Loss of cell proliferation in senescent cells was associated with impaired ERK1/2 activation, which was caused by p53-mediated elevation of MKP-3. The p53/MKP-3/ERK1/2 cascade contributed to the establishment of the senescent phenotype." @default.
• W1983846798 created "2016-06-24" @default.
• W1983846798 creator A5003759585 @default.
• W1983846798 creator A5005404256 @default.
• W1983846798 creator A5077973578 @default.
• W1983846798 creator A5080600205 @default.
• W1983846798 creator A5087909041 @default.
• W1983846798 date "2015-01-01" @default.
• W1983846798 modified "2023-10-15" @default.
• W1983846798 title "p53 Protein-mediated Up-regulation of MAP Kinase Phosphatase 3 (MKP-3) Contributes to the Establishment of the Cellular Senescent Phenotype through Dephosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2)" @default.
• W1983846798 cites W1513261706 @default.
• W1983846798 cites W1521411817 @default.
• W1983846798 cites W1642857149 @default.
• W1983846798 cites W1964333754 @default.
• W1983846798 cites W1965790167 @default.
• W1983846798 cites W1966826646 @default.
• W1983846798 cites W1970891016 @default.
• W1983846798 cites W1978888457 @default.
• W1983846798 cites W1992090578 @default.
• W1983846798 cites W2008287278 @default.
• W1983846798 cites W2009668465 @default.
• W1983846798 cites W2015519364 @default.
• W1983846798 cites W2020043044 @default.
• W1983846798 cites W2020592563 @default.
• W1983846798 cites W2022330077 @default.
• W1983846798 cites W2024068850 @default.
• W1983846798 cites W2025664838 @default.
• W1983846798 cites W2027931017 @default.
• W1983846798 cites W2038696352 @default.
• W1983846798 cites W2047330128 @default.
• W1983846798 cites W2055380229 @default.
• W1983846798 cites W2058135827 @default.
• W1983846798 cites W2058638257 @default.
• W1983846798 cites W2061227901 @default.
• W1983846798 cites W2062107951 @default.
• W1983846798 cites W2063955417 @default.
• W1983846798 cites W2064129448 @default.
• W1983846798 cites W2065568194 @default.
• W1983846798 cites W2070061120 @default.
• W1983846798 cites W2086844275 @default.
• W1983846798 cites W2086920665 @default.
• W1983846798 cites W2087286926 @default.
• W1983846798 cites W2087404852 @default.
• W1983846798 cites W2088481957 @default.
• W1983846798 cites W2089218510 @default.
• W1983846798 cites W2097073373 @default.
• W1983846798 cites W2099498093 @default.
• W1983846798 cites W2101326169 @default.
• W1983846798 cites W2104785885 @default.
• W1983846798 cites W2104908670 @default.
• W1983846798 cites W2112196790 @default.
• W1983846798 cites W2113300873 @default.
• W1983846798 cites W2116437342 @default.
• W1983846798 cites W2118656013 @default.
• W1983846798 cites W2122231684 @default.
• W1983846798 cites W2122770676 @default.
• W1983846798 cites W2130084958 @default.
• W1983846798 cites W2137708600 @default.
• W1983846798 cites W2137979644 @default.
• W1983846798 cites W2138686544 @default.
• W1983846798 cites W2152945758 @default.
• W1983846798 cites W2161696777 @default.
• W1983846798 cites W2163667875 @default.
• W1983846798 doi "https://doi.org/10.1074/jbc.m114.590943" @default.
• W1983846798 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4294480" @default.
• W1983846798 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25414256" @default.
• W1983846798 hasPublicationYear "2015" @default.
• W1983846798 type Work @default.
• W1983846798 sameAs 1983846798 @default.
• W1983846798 citedByCount "20" @default.
• W1983846798 countsByYear W19838467982015 @default.
• W1983846798 countsByYear W19838467982016 @default.
• W1983846798 countsByYear W19838467982017 @default.
• W1983846798 countsByYear W19838467982018 @default.
• W1983846798 countsByYear W19838467982019 @default.
• W1983846798 countsByYear W19838467982021 @default.
• W1983846798 countsByYear W19838467982022 @default.
• W1983846798 countsByYear W19838467982023 @default.
• W1983846798 crossrefType "journal-article" @default.
• W1983846798 hasAuthorship W1983846798A5003759585 @default.
• W1983846798 hasAuthorship W1983846798A5005404256 @default.
• W1983846798 hasAuthorship W1983846798A5077973578 @default.
• W1983846798 hasAuthorship W1983846798A5080600205 @default.
• W1983846798 hasAuthorship W1983846798A5087909041 @default.
• W1983846798 hasBestOaLocation W19838467981 @default.
• W1983846798 hasConcept C11960822 @default.
• W1983846798 hasConcept C178666793 @default.
• W1983846798 hasConcept C181912034 @default.
• W1983846798 hasConcept C184235292 @default.
• W1983846798 hasConcept C522857546 @default.
• W1983846798 hasConcept C55493867 @default.
• W1983846798 hasConcept C62112901 @default.
• W1983846798 hasConcept C86803240 @default.
• W1983846798 hasConcept C95444343 @default.
• W1983846798 hasConceptScore W1983846798C11960822 @default.
• W1983846798 hasConceptScore W1983846798C178666793 @default.
• W1983846798 hasConceptScore W1983846798C181912034 @default.
• W1983846798 hasConceptScore W1983846798C184235292 @default.

• next